Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313361023> ?p ?o ?g. }
- W4313361023 endingPage "73" @default.
- W4313361023 startingPage "73" @default.
- W4313361023 abstract "The attenuated yellow fever (YF) vaccine is one of the most successful vaccines ever developed. After a single dose administration YF vaccine can induce balanced Th1/Th2 immune responses and long-lasting neutralizing antibodies. These attributes endorsed it as a model of how to properly stimulate the innate response to target protective immune responses. Despite their longstanding success, attenuated YF vaccines can cause rare fatal adverse events and are contraindicated for persons with immunosuppression, egg allergy and age < 6 months and >60 years. These drawbacks have encouraged the development of a non-live vaccine. The aim of the present study is to characterize and compare the immunological profile of two adjuvant formulations of an inactivated YF 17DD vaccine candidate. Inactivated YF vaccine formulations based on alum (Al(OH)3) or squalene (AddaVax®) were investigated by immunization of C57BL/6 mice in 3-dose or 2-dose schedules, respectively, and compared with a single dose of attenuated YF virus 17DD. Sera were analyzed by ELISA and Plaque Reduction Neutralization Test (PRNT) for detection of total IgG and neutralizing antibodies against YF virus. In addition, splenocytes were collected to evaluate cellular responses by ELISpot. Both inactivated formulations were able to induce high titers of IgG against YF, although neutralizing antibodies levels were borderline on pre-challenge samples. Analysis of IgG subtypes revealed a predominance of IgG2a associated with improved neutralizing capacity in animals immunized with the attenuated YF vaccine, and a predominance of IgG1 in groups immunized with experimental non-live formulations (alum and AddaVax®). After intracerebral (IC) challenge, attenuated and inactivated vaccine formulations showed an increase in neutralizing antibodies. The AddaVax®-based inactivated vaccine and the attenuated vaccine achieved 100% protection, and alum-based equivalent formulation achieved 70% protection." @default.
- W4313361023 created "2023-01-06" @default.
- W4313361023 creator A5018209745 @default.
- W4313361023 creator A5051029968 @default.
- W4313361023 creator A5051944880 @default.
- W4313361023 creator A5053799796 @default.
- W4313361023 creator A5055017119 @default.
- W4313361023 creator A5055894776 @default.
- W4313361023 creator A5062963511 @default.
- W4313361023 creator A5068393561 @default.
- W4313361023 creator A5068479213 @default.
- W4313361023 creator A5085130153 @default.
- W4313361023 creator A5085604961 @default.
- W4313361023 date "2022-12-28" @default.
- W4313361023 modified "2023-09-25" @default.
- W4313361023 title "Evaluation of Two Adjuvant Formulations for an Inactivated Yellow Fever 17DD Vaccine Candidate in Mice" @default.
- W4313361023 cites W1584388723 @default.
- W4313361023 cites W1590798843 @default.
- W4313361023 cites W1762992946 @default.
- W4313361023 cites W1840529379 @default.
- W4313361023 cites W1934848916 @default.
- W4313361023 cites W1969106394 @default.
- W4313361023 cites W1974338321 @default.
- W4313361023 cites W1979195886 @default.
- W4313361023 cites W1981870459 @default.
- W4313361023 cites W1994415441 @default.
- W4313361023 cites W1999045621 @default.
- W4313361023 cites W2000045275 @default.
- W4313361023 cites W2005333995 @default.
- W4313361023 cites W2013769497 @default.
- W4313361023 cites W2017990978 @default.
- W4313361023 cites W2028587022 @default.
- W4313361023 cites W2030216544 @default.
- W4313361023 cites W2035671081 @default.
- W4313361023 cites W2045978363 @default.
- W4313361023 cites W2047641905 @default.
- W4313361023 cites W2062715434 @default.
- W4313361023 cites W2063996382 @default.
- W4313361023 cites W2065486680 @default.
- W4313361023 cites W2079716171 @default.
- W4313361023 cites W2082450387 @default.
- W4313361023 cites W2083730757 @default.
- W4313361023 cites W2090008724 @default.
- W4313361023 cites W2090646303 @default.
- W4313361023 cites W2096927399 @default.
- W4313361023 cites W2101991095 @default.
- W4313361023 cites W2126788431 @default.
- W4313361023 cites W2129509656 @default.
- W4313361023 cites W2171633892 @default.
- W4313361023 cites W2587035337 @default.
- W4313361023 cites W2739393808 @default.
- W4313361023 cites W2764009809 @default.
- W4313361023 cites W2767110860 @default.
- W4313361023 cites W2803559194 @default.
- W4313361023 cites W2807168095 @default.
- W4313361023 cites W2942730394 @default.
- W4313361023 cites W2952495989 @default.
- W4313361023 cites W3048167828 @default.
- W4313361023 cites W3096001390 @default.
- W4313361023 cites W3144140615 @default.
- W4313361023 cites W4200590191 @default.
- W4313361023 cites W4200604345 @default.
- W4313361023 doi "https://doi.org/10.3390/vaccines11010073" @default.
- W4313361023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36679918" @default.
- W4313361023 hasPublicationYear "2022" @default.
- W4313361023 type Work @default.
- W4313361023 citedByCount "1" @default.
- W4313361023 countsByYear W43133610232023 @default.
- W4313361023 crossrefType "journal-article" @default.
- W4313361023 hasAuthorship W4313361023A5018209745 @default.
- W4313361023 hasAuthorship W4313361023A5051029968 @default.
- W4313361023 hasAuthorship W4313361023A5051944880 @default.
- W4313361023 hasAuthorship W4313361023A5053799796 @default.
- W4313361023 hasAuthorship W4313361023A5055017119 @default.
- W4313361023 hasAuthorship W4313361023A5055894776 @default.
- W4313361023 hasAuthorship W4313361023A5062963511 @default.
- W4313361023 hasAuthorship W4313361023A5068393561 @default.
- W4313361023 hasAuthorship W4313361023A5068479213 @default.
- W4313361023 hasAuthorship W4313361023A5085130153 @default.
- W4313361023 hasAuthorship W4313361023A5085604961 @default.
- W4313361023 hasBestOaLocation W43133610231 @default.
- W4313361023 hasConcept C104317684 @default.
- W4313361023 hasConcept C138894074 @default.
- W4313361023 hasConcept C159047783 @default.
- W4313361023 hasConcept C159654299 @default.
- W4313361023 hasConcept C167672396 @default.
- W4313361023 hasConcept C203014093 @default.
- W4313361023 hasConcept C22070199 @default.
- W4313361023 hasConcept C2522874641 @default.
- W4313361023 hasConcept C2777034457 @default.
- W4313361023 hasConcept C2777704310 @default.
- W4313361023 hasConcept C2777863537 @default.
- W4313361023 hasConcept C2779053233 @default.
- W4313361023 hasConcept C2779131611 @default.
- W4313361023 hasConcept C2779261636 @default.
- W4313361023 hasConcept C2779308166 @default.
- W4313361023 hasConcept C2779635636 @default.
- W4313361023 hasConcept C2780801004 @default.